Aly Razek

424 total citations
12 papers, 293 citations indexed

About

Aly Razek is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Aly Razek has authored 12 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 4 papers in Surgery and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Aly Razek's work include Sarcoma Diagnosis and Treatment (6 papers), Acute Lymphoblastic Leukemia research (4 papers) and Neuroblastoma Research and Treatments (2 papers). Aly Razek is often cited by papers focused on Sarcoma Diagnosis and Treatment (6 papers), Acute Lymphoblastic Leukemia research (4 papers) and Neuroblastoma Research and Treatments (2 papers). Aly Razek collaborates with scholars based in United States. Aly Razek's co-authors include Teresa J. Vietti, Fred Valeriote, E. Omer Burgert, John M. Kissane, Edmund A. Gehan, Melvin Tefft, Carlos A. Perez, Mark E. Nesbit, Shigeru Tokiwa and Minoru Endo and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Aly Razek

12 papers receiving 257 citations

Peers

Aly Razek
Z Voboril Czechia
Can Öztürk Türkiye
B Egloff Switzerland
Jay Bowen United States
H Mahera Greece
Arthur Schantz United States
C. Cellier France
J Fujita Japan
Aly Razek
Citations per year, relative to Aly Razek Aly Razek (= 1×) peers Masashi Kusakabe

Countries citing papers authored by Aly Razek

Since Specialization
Citations

This map shows the geographic impact of Aly Razek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aly Razek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aly Razek more than expected).

Fields of papers citing papers by Aly Razek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aly Razek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aly Razek. The network helps show where Aly Razek may publish in the future.

Co-authorship network of co-authors of Aly Razek

This figure shows the co-authorship network connecting the top 25 collaborators of Aly Razek. A scholar is included among the top collaborators of Aly Razek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aly Razek. Aly Razek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Thomas, Patrick R., Jeannette Y. Lee, Barbara Fineberg, et al.. (1984). An analysis of neuroblastoma at a single institution. Cancer. 53(10). 2079–2082. 24 indexed citations
2.
Razek, Aly, Fred Valeriote, & Teresa J. Vietti. (1980). Effect of dose fractionation of daunorubicin on survival of leukemic cells.. PubMed. 40(8 Pt 1). 2835–8. 1 indexed citations
3.
Razek, Aly, Carlos A. Perez, Melvin Tefft, et al.. (1980). Intergroup Ewing's sarcoma study. Local control related to radiation dose, volume, and site of primary lesion in Ewing's sarcoma. Cancer. 46(3). 516–521. 73 indexed citations
4.
Kanazawa, Akio, Shin‐ichi Teshima, Shigeru Tokiwa, Minoru Endo, & Aly Razek. (1979). Effects of short-necked clam phospholipids on the growth of prawn.. NIPPON SUISAN GAKKAISHI. 45(8). 961–965. 46 indexed citations
5.
Chu, Jen‐Yih, et al.. (1978). Childhood embryonal carcinoma of testis, report of two unusual cases, and the implication on clinical management. Medical and Pediatric Oncology. 4(2). 175–180. 2 indexed citations
6.
Tefft, Melvin, Aly Razek, Carlos Pérez, et al.. (1978). Local control and survival related to radiation dose and volume and to chemotherapy in non-metastatic Ewing's sarcoma of pelvic bones. International Journal of Radiation Oncology*Biology*Physics. 4(5-6). 367–372. 28 indexed citations
7.
Tefft, Melvin, Aly Razek, Carlos A. Pérez, et al.. (1977). Local control and survival related to radiation dose and volume and to chemotherapy in Ewing's sarcoma in the pelvis. International Journal of Radiation Oncology*Biology*Physics. 2. 27–27. 1 indexed citations
8.
Razek, Aly, et al.. (1977). Combined treatment modalities of rhabdomyosarcoma in children. Cancer. 39(6). 2415–2421. 18 indexed citations
9.
Pérez, Carlos A., Aly Razek, Melvin Tefft, et al.. (1977). Analysis of local tumor control in ewing's sarcoma.Preliminary results of a cooperative intergroup study. Cancer. 40(6). 2864–2873. 44 indexed citations
10.
Razek, Aly, Teresa J. Vietti, & Fred Valeriote. (1974). Optimum time sequence for the administration of vincristine and cyclophosphamide in vivo.. PubMed. 34(8). 1857–61. 26 indexed citations
11.
Razek, Aly, Frederick A. Valeriote, & Teresa J. Vietti. (1973). Survival of Hematopoietic and Leukemic Colony-Forming Cells In Vivo AfterAdministration of Mitomycin C or Porfiromycin2. JNCI Journal of the National Cancer Institute. 51(6). 1845–1848. 1 indexed citations
12.
Razek, Aly, Fred Valeriote, & Teresa J. Vietti. (1972). Survival of hematopoietic and leukemic colony-forming cells in vivo following the administration of daunorubicin or adriamycin.. The Mouseion at the JAXlibrary (Jackson Laboratory). 32(7). 1496–500. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026